MedPath

Prevalence of Obstructive Sleep Apnea (OSA) after treatment for advance stage head and neck cancer

Recruiting
Conditions
obstructive sleep apnea
sleep apnea
10046304
Registration Number
NL-OMON48756
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
196
Inclusion Criteria

More than one year after treatment for T3-4 oral cavity, oropharynx, hypopharynx or larynx cancer.

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Prevalence of obstructive sleep apnea </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Subgroups with a higher risk on obstructive sleep apnea and the difference in<br /><br>quality of life between patients with and without obstructive sleep apnea </p><br>
© Copyright 2025. All Rights Reserved by MedPath